345 related articles for article (PubMed ID: 16151405)
1. Human antibodies from transgenic animals.
Lonberg N
Nat Biotechnol; 2005 Sep; 23(9):1117-25. PubMed ID: 16151405
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Characterization of variable regions of monoclonal antibodies by top-down mass spectrometry.
Zhang Z; Shah B
Anal Chem; 2007 Aug; 79(15):5723-9. PubMed ID: 17591752
[TBL] [Abstract][Full Text] [Related]
4. Technology insight: cytotoxic drug immunoconjugates for cancer therapy.
Ricart AD; Tolcher AW
Nat Clin Pract Oncol; 2007 Apr; 4(4):245-55. PubMed ID: 17392715
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes].
Siberil S; Dutertre CA; Boix C; Teillaud JL
Transfus Clin Biol; 2005 Jun; 12(2):114-22. PubMed ID: 15907389
[TBL] [Abstract][Full Text] [Related]
6. Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus.
Zhang M; Zharikova D; Mozdzanowska K; Otvos L; Gerhard W
Mol Immunol; 2006 Jul; 43(14):2195-206. PubMed ID: 16472860
[TBL] [Abstract][Full Text] [Related]
7. Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins.
Navazza V; Gabba S; Alfieri A; Giorgetti S; Marchese L; Palladini G; Mattevi A; Ascari E; Caporali R; Montecucco C; Merlini G; Perfetti V
Mol Immunol; 2008 Mar; 45(5):1519-24. PubMed ID: 17949814
[TBL] [Abstract][Full Text] [Related]
8. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
[TBL] [Abstract][Full Text] [Related]
9. Design and characterization of a plasmid vector system capable of rapid generation of antibodies of multiple isotypes and specificities.
Morrow MP; Pankhong P; Weiner DB
Biotechnol Lett; 2009 Jan; 31(1):13-22. PubMed ID: 18777012
[TBL] [Abstract][Full Text] [Related]
10. Design of humanized antibodies: from anti-Tac to Zenapax.
Tsurushita N; Hinton PR; Kumar S
Methods; 2005 May; 36(1):69-83. PubMed ID: 15848076
[TBL] [Abstract][Full Text] [Related]
11. Engineered antibody fragments and the rise of single domains.
Holliger P; Hudson PJ
Nat Biotechnol; 2005 Sep; 23(9):1126-36. PubMed ID: 16151406
[TBL] [Abstract][Full Text] [Related]
12. Isolation of human antibody repertoires with preservation of the natural heavy and light chain pairing.
Meijer PJ; Andersen PS; Haahr Hansen M; Steinaa L; Jensen A; Lantto J; Oleksiewicz MB; Tengbjerg K; Poulsen TR; Coljee VW; Bregenholt S; Haurum JS; Nielsen LS
J Mol Biol; 2006 May; 358(3):764-72. PubMed ID: 16563430
[TBL] [Abstract][Full Text] [Related]
13. Humanized antibodies as potential drugs for therapeutic use.
Merluzzi S; Figini M; Colombatti A; Canevari S; Pucillo C
Adv Clin Path; 2000 Apr; 4(2):77-85. PubMed ID: 11080787
[TBL] [Abstract][Full Text] [Related]
14. [Monoclonal antibodies and therapeutics].
Desgranges C
Pathol Biol (Paris); 2004 Jul; 52(6):351-64. PubMed ID: 15261379
[TBL] [Abstract][Full Text] [Related]
15. Recombinant polymeric IgG anti-Rh: a novel strategy for development of direct agglutinating reagents.
Montano RF; Penichet ML; Blackall DP; Morrison SL; Chintalacharuvu KR
J Immunol Methods; 2009 Jan; 340(1):1-10. PubMed ID: 18848836
[TBL] [Abstract][Full Text] [Related]
16. Humanisation of monoclonal antibodies for therapy.
Gorman SD; Clark MR
Semin Immunol; 1990 Nov; 2(6):457-66. PubMed ID: 2104282
[TBL] [Abstract][Full Text] [Related]
17. Analyzing the "degree of humanness" of antibody sequences.
Abhinandan KR; Martin AC
J Mol Biol; 2007 Jun; 369(3):852-62. PubMed ID: 17442342
[TBL] [Abstract][Full Text] [Related]
18. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
[TBL] [Abstract][Full Text] [Related]
19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
20. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
Narayanan A; Sellers BD; Jacobson MP
J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
